Go to Top

Tag Archives

Tag Archives: SVNT

Savient Pharmaceuticals (SVNT): Election of Genzyme CEO Dr. David Meeker to Its Board of Directors

Savient Pharmaceuticals (NASDAQ: SVNT) operates as a specialty biopharmaceutical company in the United States. It engages in developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary …Read More